Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The hepatitis C virus (HCV) RNA-directed RNA polymerase, also known as NS5B, is a virally encoded enzyme essential for the replication of the HCV genome. It catalyzes the synthesis of new viral RNA strands using an existing viral RNA template, a process fundamental to the life cycle of HCV. It is a major target for antiviral drugs.
Inhibition of viral RNA synthesis
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatitis C Virus RNA-Directed RNA Polymerase (NS5B).